CLINICAL ROLE -
Optimal Treatment of Schizophrenia: Take-Home Messages
Overcoming Obstacles to LAIs in Schizophrenia Management
Schizophrenia: Switching to a Long-Acting Injectable
Benefit of Long Acting Injectables in Schizophrenia
Adherence to Oral Agents in Schizophrenia Management
Schizophrenia: Understanding the Impact of Adherence
Schizophrenia: Consequences of Multiple Relapses
Importance of Relapse Prevention in Schizophrenia
Unmet Needs and Challenges in Managing Schizophrenia
OneKey Solutions and the Pharmacy Workflow
Ed Cohen discusses platform integration in the pharmacy.
Strategies to Mitigate the Rising Cancer Cost Burden
Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, discusses the increasing cost burden of cancer therapies and future strategies for mitigating costs.
Pharmacy Week in Review: VA Telehealth Initiative Announced, Cancer Treatments' Aging Effects Lead to Cognitive Decline
A look at last week's top stories in the world of pharmacy.
December 14 Pharmacy Week in Review: Walmart Announces New Telehealth Service for Veterans, Study Weighs Risks and Benefits of Statins
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Advances in Current and Emerging Therapies for Hemophilia
Tim Boonstra, RPh, Pharmacy Manager at Fairview Center for Bleeding and Clotting Disorders, talks about new therapies for hemophilia and exciting advancements on the horizon.
Depression and Burnout
In this video, David Hager, PharmD, BCPS, the director of clinical pharmacy services at UW Health, Madison, WI, discusses the relationship between burnout and depression.
Adherence With CDK 4/6 Inhibitors
Patient Management of CDK 4/6 Inhibitors
Dispensing of CDK4/6 Inhibitors
Multidisciplinary Approach: Managing CDK4/6 Inhibitors
Patients' Perspectives on CDK4/6 Inhibitors
Benefits and Challenges of CDK4/6 Inhibitors
Metastatic Breast Cancer: CDK4/6 Inhibitors
Improving Care for Patients With Metastatic Breast Cancer
Educating Patients and Staff on Using CDK4/6 Inhibitors
Best Practices for Managing Patients on CDK4/6 Inhibitors
Multidisciplinary Care in Breast Cancer
Considerations for Treating Patients with CDK4/6 Inhibitors
CDK4/6 Inhibitors in Metastatic Breast Cancer
Medically Integrated Pharmacy Teams Spur Innovations
Oral Oncolytics and Patient Adherence
